Clinical Trial Update: Efficacy and Safety of Ultra-low Dose Methadone as Adjuvant Analgesic in Cancer Patients With Pain [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ultra-low dose methadone as an adjuvant analgesic for cancer-related pain; efficacy and safety results have not been reported in this u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Methadone (methadone)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Pain, Intractable | Phase 3 | Status: UNKNOWN